Order Article Reprints

Dueñas-Gutiérrez C, Buzón L, Pedrero-Tomé R, Iribarren JA, De los Santos I, De la Fuente S, Pousada G, Moran MA, Moreno E, Ferreira E, et al. Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses. 2023; 15(4):936. https://doi.org/10.3390/v15040936

Dueñas-Gutiérrez, Carlos, Luis Buzón, Roberto Pedrero-Tomé, José A. Iribarren, Ignacio De los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, and et al. 2023. "Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV" Viruses 15, no. 4: 936. https://doi.org/10.3390/v15040936

Dueñas-Gutiérrez, C., Buzón, L., Pedrero-Tomé, R., Iribarren, J. A., De los Santos, I., De la Fuente, S., Pousada, G., Moran, M. A., Moreno, E., Ferreira, E., Gómez, J., & Troya, J. (2023). Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses, 15(4), 936. https://doi.org/10.3390/v15040936